Improving the outcomes of anticoagulation: An evaluation of home follow-up of warfarin initiation

Journal of Internal Medicine

Volumn 256, Issue 2, 2004, Pages 137-144

  Jackson, S L ^a   Peterson, G M ^a   Vial, J H ^a   Jupe, D M L ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Anticoagulation; Education; Haemorrhage; INR monitoring; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HOME MONITORING; HOSPITALIZATION; HUMAN; INTERNATIONAL STANDARD UNIT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RANDOMIZATION; SIDE EFFECT; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FAMILY PRACTICE; FEMALE; HEMORRHAGE; HOUSE CALLS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT EDUCATION; PHARMACISTS; POINT-OF-CARE SYSTEMS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; WARFARIN;

EID: 3242880015     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01352.x     Document Type: Article

References (32)

1. Rigby K, Clark R, Runciman W. Adverse events in health care: setting priorities based on economic evaluation. J Qual Clin Pract 1999; 19: 7-12.
2. Levine MN. Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment [Review]. Chest 2001; 119: 108S-21S.
3. Fihn SD, McDonell M, Martin D et al. Risk-factors for complications of chronic anticoagulation - a multicenter study. Ann Intern Med 1993; 118: 511-20.
4. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding - clinical epidemiology, prediction, and prevention. Am J Med 1993; 95: 315-28.
5. White RH, Beyth RJ, Zhou H, Romano PS. Major bleeding after hospitalization for deep-venous thrombosis. Am J Med 1999; 107: 414-24.
6. Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-8.
7. Petitti DB, Strom BL, Melmon KL. Duration of warfarin anticoagulant-therapy and the probabilities of recurrent thromboembolism and hemorrhage. Am J Med 1986; 81: 255-9.
8. Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 2001; 35: 539-45.
9. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003; 138: 161-7.
10. Kovacs MJ, Rodger MA, Anderson DR et al. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular weight heparin for outpatient treatment of acute venous thromboembolism. Ann Intern Med 2003; 138: 714-9.
11. Pengo V, Zasso A, Barbero F, Biasiolo A, Rampazzo P, Brocco T. Initiation of warfarin treatment in outpatients with nonrheumatic atrial fibrillation - a scheme for early indication of maintenance dose. Clin Appl Thromb Hemost 1998; 4: 274-6.
12. Roberts GW, Helboe T, Nielsen CBM et al. Assessment of an age-adjusted warfarin initiation protocol. Ann Pharmacother 2003; 37: 799-803.
13. Heidinger KS, Bernardo A, Taborski U, Muller-Berghaus G. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis. Thromb Res 2000; 98: 287-93.
14. Hirsh J, Dalen JE, Anderson DR et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range [Review]. Chest 2001; 119: 8S-21.
15. Corbett NE, Peterson GM. Review of the initiation of anticoagulant therapy. J Clin Pharm Ther 1995; 20: 221-4.
16. Gage BF, Fihn SD, White RH. Warfarin therapy for an octogenarian who has atrial fibrillation. Ann Intern Med 2001; 134: 465-74.
17. Beyth RJ. Hemorrhagic complications of oral anticoagulant therapy. Clin Geriatr Med 2001; 17: 49-56.
18. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003; 107: 1692-711.
19. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events - implications for prevention. JAMA 1995; 274: 29-34.
20. Senst BL, Achusim LE. Genest RP et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58: 1126-32.
21. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003; 163: 2014-8.
22. Kistler JP, The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.
23. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial-Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991; 18: 349-55.
24. Ezekowitz MD, Bridgers SL, James KE et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992; 327: 1406-12.
25. Petersen P, Boysen G, Godtfredsen J, Andersen FD, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1: 175-9.
26. Stroke Prevention in Atrial Fibrillation study group. Stroke prevention in atrial-fibrillation study - final results. Circulation 1991; 84: 527-39.
27. Palareti G, Manotti C, Dangelo A et al. Thrombotic events during oral anticoagulant treatment: results of the inceptioncohort, prospective, collaborative ISCOAT study. Thromb Haemost 1997; 78: 1438-43.
28. Landefeld CS, McGuire E, Rosenblatt MW. A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1990; 89: 569-78.
29. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin - a randomized, controlled trial. Ann Intern Med 2000; 133: 687-95.
30. Arnsten JH, Gelfand JM, Singer DE, Determinants of compliance with anticoagulation: a case-control study. Am J Med 1997; 103: 11-7.
31. Brigden ML, Kay C, Le A, Graydon C, McLeod B. Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population. Am J Hematol 1998; 59: 22-7.
32. McCormack PME, Stinson JC, Hemeryck L, Feely J. Audit of an anticoagulant clinic: doctor and patient knowledge. Jr Med J 1997; 90: 192-3.